Human-induced pluripotent stem cell-derived cardiomyocytes to study PUFA analogues as a potential treatment of long QT syndrome

被引：0
|
作者：
de la Cruz, Alicia [1 ]
Dykxhoorn, Derek M. [1 ]
Barro-Soria, Rene [1 ]
Agarwal, Ashutosh [1 ]
Larsson, Peter H. [1 ]
机构：
[1] Univ Miami, Miami, FL USA
来源：
BIOPHYSICAL JOURNAL | 2023年 / 122卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
1230-Pos
引用
收藏
页码：253A / 253A
页数：1
相关论文
共 50 条
  • [1] Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    El-Battrawy, Ibrahim
    Lan, Huan
    Cyganek, Lukas
    Zhao, Zhihan
    Li, Xin
    Buljubasic, Fanis
    Lang, Siegfried
    Yucel, Gokhan
    Sattler, Katherine
    Zimmermann, Wolfram-Hubertus
    Utikal, Jochen
    Wieland, Thomas
    Ravens, Ursula
    Borggrefe, Martin
    Zhou, Xiao-Bo
    Akin, Ibrahim
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (07):
  • [2] Human induce pluripotent stem cell-derived cardiomyocyte model to study PUFA analogs as a potential treatment of long QT syndrome
    de la Cruz, Alicia
    Dykxhoorn, Derek M.
    Agarwal, Ashutosh
    Larsson, Peter H.
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 230A - 231A
  • [3] Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells
    Sala, Luca
    Gnecchi, Massimiliano
    Schwartz, Peter J.
    ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2019, 8 (02) : 105 - 110
  • [4] Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Song, Yongfei
    Zheng, Zequn
    Lian, Jiangfang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [5] HUMAN MYOFIBROBLASTS INCREASE THE ARRHYTHMOGENIC POTENTIAL OF HUMAN-INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES
    Johnson, R. D.
    Mcvey, J. H.
    Camelliti, P.
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (02) : 280 - 281
  • [6] Drug Testing in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
    Zhao, Zhihan
    Li, Xin
    El-Battrawy, Ibrahim
    Lan, Huan
    Zhong, Rujia
    Xu, Qiang
    Huang, Mengying
    Liao, Zhenxing
    Lang, Siegfried
    Zimmermann, Wolfram-Hubertus
    Cyganek, Lukas
    Wieland, Thomas
    Akin, Ibrahim
    Zhou, Xiao-Bo
    Borggrefe, Martin
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (03) : 642 - 651
  • [7] Drug-testing using human-induced pluripotent stem cell-derived cardiomyocytes from a patient with short QT syndrome
    Zhao, Z.
    Lan, H.
    Li, X.
    El-Battrawy, I.
    Xu, Q.
    Huang, M.
    Zhong, R.
    Liao, Z.
    Lang, S.
    Cyganek, L.
    Zimmermann, W. H.
    Wieland, T.
    Borggrefe, M.
    Zhou, X. B.
    Akin, I.
    EUROPEAN HEART JOURNAL, 2018, 39 : 600 - 600
  • [8] Assessment of Cardiomyocyte Contraction in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Pointon, Amy
    Harmer, Alexander R.
    Dale, Ian L.
    Abi-Gerges, Najah
    Bowes, Joanne
    Pollard, Christopher
    Garside, Helen
    TOXICOLOGICAL SCIENCES, 2015, 144 (02) : 227 - 237
  • [9] Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes
    A. D. Podgurskaya
    M. M. Slotvitsky
    V. A. Tsvelaya
    S. R. Frolova
    S. G. Romanova
    V. A. Balashov
    K. I. Agladze
    Scientific Reports, 11
  • [10] Human-induced pluripotent stem cell-derived cardiomyocytes: phenotypic and functional variability
    Koivumaki, J.
    Nikolay, N.
    Tuomainen, T.
    Takalo, J.
    Tavi, P.
    ACTA PHYSIOLOGICA, 2017, 219 : 4 - 4
12345